Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Great Emphasis is Put on Research.

Boehringer Ingelheim acquires Tyrolean biotech company ViraTherapeutics

© Boehringer Ingelheim

The startup which was spun off from the University of Innsbruck in 2013 focuses on the development of oncolytic viral therapies serving as an immunotherapy in the fight against cancer. "The acquisition strengthens Boehringer Ingelheim's commitment to research and development of viral-based immuno-oncology treatment options for cancer patients", says Boehringer Ingelheim.

The company has already been involved with ViraTherapeutics since 2016 together with EMBL Ventures. ViraTherapeutics will become a separate unit of Boehringer Ingelheim's research organization. 19 researchers are currently employed at the facility in Innsbruck. Up until now the shares in ViraTherapeutics were held by Boehringer Ingelheim Venture Fonds, which acquires stakes in innovative startups in the pharmaceutical sector. 22 young companies are currently in the Boehringer Ingelheim portfolio. Boehringer Ingelheim is very strongly committed to both research and production in Austria. The entire cancer research of the company is bundled in Vienna. At present the Group is investing about EUR 700 million in a new biotech production plant in Vienna.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us @ CEE UNLIMITED

    15.10.2019, Budapest, Hungary

  • Meet us @ GoTech

    13. - 17.10.2019, Moscow, Russia

Austria Map

Find the perfect location for your company

The new Amazon distribution center in Großebersdorf is our first logistics site in Austria It will enable us to create additional and more flexible delivery capacities for the benefit of customers. We feel that we are in good hands, also thanks to the support of ABA – Invest in Austria.

Amazon

amazon.de
More testimonials

news from the business location Austria

Vienna University of Technology involved in developing a nuclear clock

A revolution is in the making. The nuclear clock is the measure of all things when it comes to precisely telling time. However, the technology has not fully matured, and nuclear clocks could potentially tick even more precisely.

How Austria Shapes Its Future with AI

Artificial intelligence (AI) is certainly the most powerful new technology available today. This is probably the reason why the underlying discussion is frequently driven by fear. Hollywood has also contributed to this. Half-human, half-machine mutants resembling Frankenstein and Terminator are the spectres unleased by AI. However, as is often the case, Hollywood’s fantasy has little to do with reality.

More news All blog posts